{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:23:26Z","timestamp":1789593806915,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.clinbiochem.2009.12.007","type":"journal-article","created":{"date-parts":[[2009,12,29]],"date-time":"2009-12-29T04:07:04Z","timestamp":1262059624000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Empirical models for dosage optimization of four \u03b2-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin"],"prefix":"10.1016","volume":"43","author":[{"given":"Isabelle K.","family":"Delattre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora T.","family":"Musuamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Verbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Dugernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Spapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Laterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wittebole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Cumps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre E","family":"Wallemacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2009.12.007_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis occurrence in acutely ill patients investigators. Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc2917","article-title":"Severe sepsis epidemiology: sampling, selection, and society","volume":"8","author":"Linde-Zwirble","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","article-title":"Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study","volume":"28","author":"Alberti","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/01.CCM.0000261890.41311.E9","article-title":"Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003","volume":"35","author":"Dombrovskiy","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","article-title":"The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection","volume":"244","author":"Leibovici","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/379825","article-title":"Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial","volume":"38","author":"MacArthur","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib10","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/519472","article-title":"Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data","volume":"45","author":"Deresinski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0924-8579(02)00020-1","article-title":"Can PK\/PD be used in everyday clinical practice","volume":"19","author":"Scaglione","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-199528020-00005","article-title":"The importance of pharmacokinetic\/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents","volume":"28","author":"Hyatt","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib13","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1086\/504383","article-title":"The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients","volume":"42","author":"Pea","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib15","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/jac\/15.suppl_A.47","article-title":"Dual individualization: antibiotic dosage calculation from the integration of in-vitro pharmacodynamics and in-vivo pharmacokinetics","volume":"15","author":"Schentag","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib16","series-title":"Applied pharmacokinetics. Principles of therapeutic drug monitoring","article-title":"Dual individualization with antibiotics: integrated antibiotic management strategies for use in hospitals","author":"Schentag","year":"1992"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00003088-200645080-00001","article-title":"Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis","volume":"45","author":"Roberts","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","article-title":"Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability","volume":"44","author":"Pea","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200241140-00002","article-title":"Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock","volume":"41","author":"De Paepe","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003088-199834010-00002","article-title":"Pharmacokinetics of drugs used in critically ill adults","volume":"34","author":"Power","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib21","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00134-004-2428-9","article-title":"Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness","volume":"30","author":"Mehrotra","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003088-198814060-00003","article-title":"The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients","volume":"14","author":"Bodenham","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diagmicrobio.2003.09.010","article-title":"Pharmacokinetic\/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients","volume":"48","author":"Mohr","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib24","series-title":"The Sepsis Text","first-page":"539","article-title":"Empirical antibiotic therapy for patients with severe sepsis and septic shock","author":"Bochud","year":"2002"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003088-200140110-00002","article-title":"Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods","volume":"40","author":"Tod","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00003088-199120050-00003","article-title":"An updated comparison of drug dosing methods. Part III: aminoglycoside antibiotics","volume":"20","author":"Erdman","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01086153","article-title":"Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients","volume":"4","author":"Sawchuk","year":"1976","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt1977213362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"21","author":"Sawchuk","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib29","series-title":"The Sanford guide to antimicrobial therapy","year":"2005"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib30","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"SCCM\/ESICM\/ACCP\/ATS\/SIS. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS. International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jat\/5.5.236","article-title":"Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma","volume":"5","author":"Jolley","year":"1981","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib34","unstructured":"Abbott Laboratories Diagnostics Division. TDxFLx\/TDx assays manual. 1990."},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib35","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Q2(R1); Validation of analytical procedures: text and methodology. Nov 2005. Available at: http:\/\/www.ich.org\/LOB\/media\/MEDIA417.pdf. Accessed November 2, 2005."},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib36","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Guidance for industry: bioanalytical method validation. May 2001. Available at: http:\/\/www.fda.gov\/cder\/Guidance\/4252fnl.pdf. Accessed November 2, 2005."},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib37","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/clinchem\/37.8.1415","article-title":"Computerized approach to monitoring aminoglycosides","volume":"37","author":"Leal","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib40","first-page":"A0828","article-title":"A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]","volume":"11","author":"Levey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib41","series-title":"Primer of Applied Regression and Analysis of Variance","first-page":"241","article-title":"Selecting the best regression model","author":"Glantz","year":"2000"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00003088-200746030-00003","article-title":"Are population pharmacokinetic and\/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004","volume":"46","author":"Brendel","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/00003088-200746100-00004","article-title":"Correlation of the pharmacokinetic parameters of amikacin and ceftazidime","volume":"46","author":"Panomvana","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.me.27.020176.001443","article-title":"Significance of serum protein and tissue binding of antimicrobial agents","volume":"27","author":"Craig","year":"1976","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/6.3.311","article-title":"The significance of protein binding of antibiotics in antibacterial chemotherapy","volume":"6","author":"Rolinson","year":"1980","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.32.1.128","article-title":"Effect of protein binding on drug penetration into blister fluid","volume":"32","author":"Shyu","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib47","series-title":"Compendium","year":"2003"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib48","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jps.1085","article-title":"Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel","volume":"90","author":"Lovich","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib49","series-title":"Clinical Pharmacokinetics. Drug data handbook","article-title":"Pharmacokinetic drug data","author":"Taeschner","year":"1998"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib50","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/AAC.34.8.1515","article-title":"Meropenem pharmacokinetics and penetration into an inflammatory exudate","volume":"34","author":"Wise","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib51","first-page":"164","article-title":"Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function","volume":"87","author":"Zaske","year":"1980","journal-title":"Surgery"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/AAC.21.3.407","article-title":"Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations","volume":"21","author":"Zaske","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib53","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1001\/jama.1982.03330230034027","article-title":"Wide interpatient variations in gentamicin dosage requirements for geriatric patients","volume":"248","author":"Zaske","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007691-200502000-00004","article-title":"Cost-Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology. Cost-effectiveness of therapeutic drug monitoring: a systematic review","volume":"27","author":"Touw","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib55","series-title":"Applied pharmacokinetics. Principles of therapeutic drug monitoring","article-title":"Special pharmacokinetic considerations in the elderly","author":"Mayersohn","year":"1992"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/514622","article-title":"The pharmacodynamics of beta-lactams","volume":"27","author":"Turnidge","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/514620","article-title":"The pharmacodynamics of aminoglycosides","volume":"27","author":"Lacy","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinbiochem.2009.12.007_bib59","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/106002809603000920","article-title":"AUIC\u2014the universal parameter within the constraint of a reasonable dosing interval","volume":"30","author":"Schentag","year":"1996","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009005554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009005554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:31:27Z","timestamp":1757863887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912009005554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0009912009005554"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.12.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empirical models for dosage optimization of four \u03b2-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}